Related Experiment Video
Updated: Aug 15, 2025
04:09
Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
3.0K
Diabetic foot ulcer: Challenges and future.
Li Yang1, Gui-Chuan Rong2, Qi-Nan Wu3
1Department of Endocrinology, Dazu Hospital of Chongqing Medical University, The People's Hospital of Dazu, Chongqing 402360, China.
World Journal of Diabetes
|December 29, 2022
Summary
Diabetic foot ulcers (DFUs) are a major complication of diabetes. Effective DFU management requires multidisciplinary approaches, including risk factor control and advanced wound care strategies.
Area of Science:
- Diabetology
- Vascular Surgery
- Wound Care
Background:
- Diabetic foot ulcers (DFUs) significantly contribute to diabetes-related mortality, morbidity, and hospitalizations.
- DFUs impose a substantial burden on patients and healthcare systems.
- Multidisciplinary management is crucial for the prevention and treatment of DFUs.
Purpose of the Study:
- To review recent advancements in the clinical practice of treating diabetic foot ulcers.
- To analyze emerging technologies and measurements in DFU treatment.
- To identify future challenges and directions in DFU care.
Main Methods:
- Comprehensive review of current clinical practices for DFU management.
- Analysis of established and novel therapeutic interventions.
- Prospective evaluation of new technologies and diagnostic measurements.
Main Results:
- Current DFU treatment involves controlling risk factors (glycemia, BP, lipids, smoking cessation).
- Local management strategies include debridement, advanced dressings, revascularization, stem cell therapy, and oxygen therapy.
- Systemic anti-infection treatment is administered when necessary.
Conclusions:
- DFU treatment necessitates a holistic, multidisciplinary approach.
- Innovations in revascularization, wound repair, offloading, stem cell transplantation, and anti-infection therapies are advancing DFU care.
- Continued research into new technologies and strategies is essential to overcome future challenges in DFU management.
Related Concept Videos
01:26Peripheral Artery Disease IV: Nursing Management
21
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
21
01:23Peripheral Artery Disease V: Postoperative Nursing Management
17
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
17
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
24
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
24
01:15Diabetes: Management and Pharmacotherapy
327
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
327
01:20Pathophysiology of Diabetes
1.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
01:15Diabetes: Symptoms, Diagnosis, and Complications
641
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
641